About: http://webisa.webdatacommons.org/21762490

Property	Value
http://www.w3.org/1999/02/22-rdf-syntax-ns#type	http://www.w3.org/ns/prov#Entity
http://www.w3.org/ns/prov#value	These documents will help companies decide the data, such as bridging studies, which they should submit to the FDA to justify the change of excipient.
http://www.w3.org/ns/prov#wasQuotedFrom	in-pharmatechnologist.com